Symptomatic intrapelvic malignant tumor
Conditions
Interventions
Radiofrequency ablation needle is percutaneouly inserted into the intrapelvic malignant tumor and radiofrequency ablation is performed.
Sponsors
Japan Interventional Radiology in Oncology Study Group (JIVROSG)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Symptomatic and uncontrollable intrapelvic malignant tumor. 2) Histologically confirmed malignant lesion. 3) Maximum diameter of lesion on image not exceed 5cm. 4) No influence of previous treatment. 5) Measurable disease on CT or MRI. 6) Any ascites in Douglas pouch allowed. 7) Lesion mainly located in intrapelvic space. 8) Adequate cardiac, hepatic, renal, respiratory, coagulation, and bone marrow functions. 9) Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 3. 10) Expected survival more than 4 weeks. 11) Written informed consent.
Exclusion criteria
Exclusion criteria: 1) No symptom or VAS of less than 3. 2) Cardiac pacemaker. 3) Artery or nerve along the puncture route. 4) Lesion or target area adjacent to critical organs. 5) Infection in the target area. 6) Pregnancy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adverse events | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement of symptom measured by Visual Analogue Scale at 1 week after the procedure. | — |
Countries
Japan
Contacts
Public ContactYasuaki Arai
JIVROSG, Coordinating Office Division of Diagnostic Radiology, National Cancer Center Hospital
Outcome results
None listed